About Us
Principal: Dr. Xiaohu Deng
Dr. Deng is a seasoned executive with 22 years of experience in the pharmaceutical and biotechnology industry with a focus on drug product development and technical operations. His track record includes numerous IND submission/clearance, clinical/registration/validation batch production and NDA preparation.
He was a Sr. Vice President, Head of Techical Operations at Vividion Therapeutics from 2021 to 2023, leading a department encompassing preclinical formulation, API process development, drug product formulation development, DS and DP cGMP manufacturing, analytical development, quality control and clinical supply. Prior to Vividion, he served as Senior Vice President, Product Development at Viracta Therapeutics, leading the CMC function and IP strategy. Prior to that, he was a Senior Director, Head of CMC at Kura Oncology, Inc. and Wellspring Biosciences, Inc., overseeing the CMC efforts on process R&D, manufacturing, compliance, regulatory and clinical supply for multiple programs through various phases of development. Earlier in his career, Dr. Deng held roles of increasing responsibility associated with chemistry R&D, CRO management and project management of discovery and preclinical development at Janssen Pharmaceutical Companies of Johnson & Johnson.
Dr. Deng holds a Ph.D. in organic chemistry from Emory University, and an M.S. in physical chemistry and a B.S. in chemistry from Fudan University in Shanghai. Dr. Deng has more than 40 journal publications, a book chapter and holds 16 published patents.
For more information, please check Dr. Deng's Linkedin page https://www.linkedin.com/in/xiaohu-deng-43905a12/.